A. Ernest Toth, Jr. is a seasoned financial executive who currently serves as the Chief Financial Officer (CFO) at Aquestive Therapeutics Inc., a pharmaceutical company focused on developing and commercializing innovative drug delivery technologies. With over 30 years of experience in the healthcare and life sciences industries, Toth has a proven track record of driving financial growth and operational efficiency. Prior to joining Aquestive Therapeutics in 2018, he held various senior financial leadership positions at notable companies such as Teva Pharmaceuticals, Cephalon, and Novartis. At Aquestive Therapeutics, Toth plays a pivotal role in shaping the company's financial strategy and overseeing its financial operations. As CFO, he is responsible for managing the company's capital structure, financial planning and analysis, accounting, and investor relations. Under his leadership, Aquestive has successfully navigated the challenges of the competitive pharmaceutical landscape, securing funding for research and development initiatives and strengthening the company's financial position. Toth's strategic vision and financial acumen have been instrumental in driving the company's growth and positioning it for long-term success. Throughout his career, Toth has demonstrated a commitment to excellence and innovation in financial management. He holds a Bachelor of Science degree in Accounting from Villanova University and is a Certified Public Accountant (CPA). His extensive experience, coupled with his dedication to Aquestive's mission of improving patient lives through innovative drug delivery solutions, makes him a valuable asset to the company and the broader pharmaceutical industry.